Largest research study on decision making of single or coupled intended fathers selected for presentation at 2021 acog annual clinical and scientific meeting and 69th annual pacific coast reproductive society meeting

New york, may 26, 2021 (globe newswire) -- progyny, inc. (nasdaq: pgny), a leading benefits management company specializing in fertility and family building benefits solutions in the united states, along with rma of connecticut, rma of new york, and stanford university partnered on the largest research study on decision making by single or coupled intended fathers in their family building using assisted reproductive technology (art) treatment to become parents.
PGNY Ratings Summary
PGNY Quant Ranking